Strategic Partnership ABM has existing licensing activity with ERS Genomics, signaling openness to collaboration and potential co-development or distribution agreements that could be extended to other gene editing, viral vectors, or recombinant services to accelerate sales.

Broad Reagent Inventory Strong product breadth spanning PCR, qPCR, antibodies, siRNA/miRNA, CRISPR, cell lines, growth factors, and viral systems suggests high cross-sell potential to labs seeking a one-stop supplier for multiple research needs.

Custom Services A dedicated R&D team offering custom recombinant viruses, cloning, gene synthesis, and protein production presents opportunities to win projects requiring tailored solutions, faster onboarding, and higher lifetime value.

Affordability Focus Messaging emphasizes cost efficiency in research, positioning ABM to target price-sensitive labs and startups seeking quality reagents at lower total cost, with potential for volume-based discounts.

Learning Resources Free educational content and sci-comm resources enhance brand authority and can drive demand generation, trials, and upsell opportunities through sponsored content, webinars, and onboarding tutorials.